Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,689,034
+$98,948 QoQ
Shares Held
10,588
-0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#2,082
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Edgemoor Investment Advisors, Inc. holds $32,892,585 across 7 Drug Manufacturers - General names. JNJ ranks #4 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,032 | $13,232,112 | |
| 2 | NVS |
Novartis AG
|
52,824 | $8,278,577 | |
| 3 | PFE |
Pfizer Inc
|
292,257 | $7,037,548 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
10,588 | $2,689,034 | |
| 5 | AMGN |
Amgen Inc
|
1,910 | $691,649 | |
| 6 | ABBV |
AbbVie Inc.
|
2,437 | $613,246 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,727 | $350,419 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,689,034 | 10,588 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,590,086 | 10,596 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,159,937 | 10,437 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,010,879 | 10,845 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,661,156 | 10,875 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,821,420 | 10,983 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,609,331 | 11,128 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,821,230 | 11,238 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,803,468 | 12,339 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $2,024,515 | 12,798 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,003,293 | 12,781 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $2,006,215 | 12,881 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,132,394 | 12,883 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,066,460 | 13,332 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $2,316,764 | 13,115 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,130,704 | 13,043 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,329,463 | 13,123 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $2,335,005 | 13,175 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,026,666 | 11,847 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,809,123 | 11,202 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $1,880,507 | 11,415 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,874,411 | 11,405 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,912,009 | 12,149 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,805,765 | 12,129 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,730,733 | 12,307 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,567,396 | 11,953 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||